Windlas Biotech Limited
Windlas Biotech Ltd is a leading domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). The company manufactures both solid and liquid pharmaceutical dosage forms and provides a comprehensive range of CDMO services ranging from product discovery, product development, and commercial manufacturing of generic products, including complex generics.
What Windlas files
- Investor Meet58
- Others37
- Updates17
- Board Meeting10
- PPTs8
- Important6
Submission of Combined Voting Results and Scrutinizer s Report under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) of the 25th Annual General Meeting held on July 23, 2026
Windlas Biotech Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 23, 2025. Further, the company has informed the Exchange regarding voting results.
Windlas Biotech Limited has informed the Exchange about the proceedings of Annual General Meeting of the Company held on July 23, 2026.
Windlas Biotech Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Windlas Biotech Limited has informed the Exchange about the Annual General Meeting to be held on July 23, 2026